Pharma Focus Asia

GeminiBio Plans to Contruct New Liquid Manufacturing Facility


GeminiBio opens new cGMP bioprocess liquid manufacturing facility in California, USA. 


This new high-volume liquid production facility significantly increases cGMP bioprocess liquids production capacity.

This new manufacturing facility enables to supply speciality cGMP cell culture media, buffers, water for injection (WFI) and other process fluids in batches of up to 10,000 litres for biotech and life sciences customers.

With the increase of large-scale process fluid production to the existing small and medium-sized capabilities enables cGMP process fluid manufacturing in sizes from 10 litres to 10,000 litres. In addition to the current 500- and 1000-litre formulation tanks, the new facility will consist of one 5000-litre and two 10,000-litre stainless steel tanks.

The production of transformative biotherapies, consisting cell and gene therapies, needs a wide range of upstream and downstream process fluids. The advanced manufacturing capability will further allow to simplify and streamline customer manufacturing flows while improving supply reliability.


Name      GeminiBio
Type        New Construction


Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Thermo Fisher Scientific - Rapid Mycoplasma TestingAsia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024Medlab Middle East 2024ISPE Singapore Affiliate Conference & Exhibition 2024